Media Center

Learn More

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

From Lab to Vaccine Vial: The Historic Manufacturing Journey of Johnson & Johnson's Janssen COVID-19 Vaccine

Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents

Johnson & Johnson Announces Agreement in Principle with Gavi to Supply Janssen’s COVID-19 Vaccine Candidate
to Lower-Income Countries in 2021

Latest Press Releases

Our Company

April 13, 2021

Johnson & Johnson Statement on COVID-19 Vaccine (Updated)

Our Company

April 12, 2021

Johnson & Johnson to Participate in the BofA Securities Virtual 2021 Healthcare Conference

Innovation

April 06, 2021

New Real-World Observational Analysis of UPTRAVI® (selexipag) Underscores the Importance of Risk Assessment for Treating Pulmonary Arterial Hypertension (PAH) Patients

Our Company

April 03, 2021

Johnson & Johnson Statement on U.S. COVID-19 Vaccine Manufacturing (Updated)

Our Company

April 02, 2021

Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents

Our Company

March 31, 2021

Johnson & Johnson Statement on U.S. COVID-19 Vaccine Manufacturing

See All Press Releases

Photos, Videos, Infographics & More

J&J Fast Facts

Our Company

We Work All Over the World

We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.

Get to know Johnson & Johnson

See All Fast Facts

Contact Media Relations

September 21, 2016

Thank you for your interest in learning more about our company. We care about your questions and concerns.

Contact Us
Stay Informed

May 25, 2018

Sign up for RSS Feed to keep you updated with latest news.

Subscribe to Feed

Social Media

Just in: @JanssenUS launched its 2020 U.S. Transparency Report today—an in-depth look at how Janssen supports patie… https://t.co/6FaMBvDOxe

JNJNews
RT @JNJGlobalHealth: This #WHWWeek, we celebrate the frontline health workers improving access to care and addressing the barriers their co…

JNJNews
"I'm a Johns Hopkins-trained epidemiologist, and I couldn't even navigate the system."—Dr. Debra Furr-Holden on her… https://t.co/8Y1NPcBlTY

JNJNews

More From Johnson & Johnson

Innovation

2 Pandemics, 1 Goal: Meet 4 Innovators with High-Tech Ideas for Fighting Tuberculosis in the Time of COVID-19

Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who've made it their mission to move the world closer to the goal of ending tuberculosis.

ON NOW

Health & Wellness

4 Things Scientists Now Know About Autoimmune Diseases in Kids

Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.

ON NOW

Image of young child with skeleton overlay

Innovation

One Year Later: The Head of Johnson & Johnson China Looks Back on What We've Learned From the Pandemic—and How It Can Help Shape the Future

The Head of Johnson & Johnson China Looks Back on What We've Learned From the Pandemic—and How It Can Help Shape the Future

Will Song's teams were on the front lines when COVID-19 shut down the city of Wuhan. One year to the day that the World Health Organization declared the disease a pandemic, he shares how the company kept going during the crisis and the innovative ideas that emerged from it.

ON NOW